Corebridge Financial’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,955
Closed -$210K 2663
2025
Q1
$210K Sell
18,955
-282
-1% -$3.12K ﹤0.01% 2048
2024
Q4
$205K Sell
19,237
-988
-5% -$10.5K ﹤0.01% 2171
2024
Q3
$257K Buy
20,225
+1,744
+9% +$22.1K ﹤0.01% 2075
2024
Q2
$310K Buy
+18,481
New +$310K ﹤0.01% 1945